SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

256 hedge funds and large institutions have $2.01B invested in Supernus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 88 increasing their positions, 98 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-5
Holders Change %
-1.92%
% of All Funds
4.1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
28
Increased
88
Reduced
98
Closed
29
Calls
$2.92M
Puts
$91K
Net Calls
+$2.83M
Net Calls Change
+$175K

Top Buyers

1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$14.1M
2
PCH
Polar Capital Holdings
United Kingdom
+$13.3M
3
IECM
Intrinsic Edge Capital Management
Illinois
+$10.5M
4
Renaissance Technologies
Renaissance Technologies
New York
+$4.82M
5
EF
Empowered Funds
Pennsylvania
+$4.51M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$15.4M
2
FCM
Frontier Capital Management
Massachusetts
-$12.7M
3
Citadel Advisors
Citadel Advisors
Florida
-$10.5M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
-$9.89M
5
LCG
Lisanti Capital Growth
New York
-$8.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
GCM
276
Gladius Capital Management
Illinois
– -$36.3K -1,019 Closed
SWA
277
Sutton Wealth Advisors
Florida
– -$25.4K -712 Closed
QT
278
Quantbot Technologies
New York
– -$18.9K -531 Closed
CS
279
Comerica Securities
Michigan
– -$8.77K -246 Closed
TC
280
Truvestments Capital
Florida
– -$2.75K -77 Closed
MCC
281
Money Concepts Capital
Florida
– -$1.93K -54 Closed
TWP
282
TFO Wealth Partners
Ohio
– -$1.28K -22 Closed
CAS
283
Coppell Advisory Solutions
Texas
– -$321 -9 Closed
CASC
284
Coppell Advisory Solutions Corp
Texas
– -$321 -9 Closed
8 9 10 11
12